The 8th annual World Drug Safety Congress was a large meeting with the top pharma, biotech and regulatory representatives in attendance. The event’s unique strategic focus provided an insightful look at the detection, analysis and prevention of adverse drug reactions with case studies, industry experiences and global regulatory coverage of developments.
Don't miss the Drug Safety US Congress in 2016! The meeting is set to bridge the gap between international regulatory bodies, industry professionals and academic representatives and will address how to drive pharmacovigilance operations forward into the 21st Century.
The 7th World Drug Safety Congress Americas brought together key thought leaders to explore increasing regulatory and patient expectations offered by big data and new technologies. Join us in 2016 to get an opportunity to engage and sit alongside the pioneers who are driving forward innovation in pharmacovigilance.
Associate Director of Safety Data Management and Office of Medical Safety Evaluation, Mitsubishi Tanabe Pharma Development America
Global Pharmacovigilance, Head TA Oncology - ICSR Processing, Bayer HealthCare Pharmaceuticals
This conference is an unrivalled and cost-effective sales and marketing solution that works throughout the year, providing you with new contacts and great exposure, culminating in an event which will bring you face-to-face with end users and key clients.
Do you want to?
Put faces to names in this fast and fun networking session
An interactive and engaging platform
where new technologies and opportunities in drug safety can be explored
SOLUTION PROVIDER EXHIBITION
Explore the exhibition hall during dedicated breaks
NETWORKING DRINKS RECEPTION
Unwind with your peers and continue
conversations in good company